International Patent: ANTI-IL-23 ANTIBODIES AND GIP/GLP-1 RECEPTOR AGONISTS FOR THE TREATMENT OF MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

GENEVA, Sept. 18 -- ELI LILLY AND COMPANY filed a patent application (US2026/017565) for “ANTI-IL-23 ANTIBODIES AND GIP/GLP-1 RECEPTOR AGONISTS FOR THE TREATMENT OF MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS”. With publication no. WO/2026/187835, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61P 1/04

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....